ICD-10: H40.123

Low-tension glaucoma, bilateral

Additional Information

Clinical Information

Low-tension glaucoma (LTG), classified under ICD-10 code H40.123, is a subtype of glaucoma characterized by optic nerve damage and visual field loss despite normal intraocular pressure (IOP) levels. Understanding its clinical presentation, signs, symptoms, and patient characteristics is crucial for effective diagnosis and management.

Clinical Presentation

Definition and Pathophysiology

Low-tension glaucoma occurs when there is damage to the optic nerve, typically associated with visual field loss, even when the IOP is within the normal range (generally considered to be 10-21 mmHg). The exact cause of optic nerve damage in LTG is not fully understood, but it may involve factors such as reduced blood flow to the optic nerve, susceptibility of the optic nerve fibers, or other systemic conditions affecting vascular health[1][2].

Signs and Symptoms

Patients with low-tension glaucoma may present with the following signs and symptoms:

  • Visual Field Loss: The most significant symptom is the gradual loss of peripheral vision, which may progress to tunnel vision. This is often asymptomatic in the early stages, making regular eye examinations essential for early detection[3].
  • Optic Nerve Changes: During an eye examination, clinicians may observe characteristic changes in the optic nerve head, such as:
  • Cupping of the optic disc (increased cup-to-disc ratio)
  • Pallor of the optic nerve head
  • Nocturnal Vision Issues: Some patients report difficulty seeing in low-light conditions, which may be attributed to the loss of rod photoreceptors in the retina[4].
  • Symptoms of Eye Discomfort: Patients may experience vague symptoms such as eye discomfort or mild headaches, although these are not specific to LTG[5].

Patient Characteristics

Demographics

  • Age: Low-tension glaucoma is more prevalent in older adults, typically affecting individuals over the age of 40[6].
  • Gender: Some studies suggest a higher prevalence in women, although this may vary by population[7].
  • Ethnicity: Certain ethnic groups, particularly those of Asian descent, may have a higher risk of developing LTG[8].

Risk Factors

Several risk factors have been identified that may predispose individuals to low-tension glaucoma:
- Family History: A family history of glaucoma increases the risk of developing the condition[9].
- Systemic Conditions: Conditions such as cardiovascular disease, diabetes, and systemic hypertension may contribute to the risk of optic nerve damage in LTG patients[10].
- Vascular Factors: Patients with low blood pressure or those who experience episodes of systemic hypotension may be at increased risk due to reduced blood flow to the optic nerve[11].

Psychological and Social Factors

Patients with low-tension glaucoma may experience psychological impacts due to the gradual loss of vision, leading to anxiety or depression. Social factors, such as limited access to healthcare or lack of awareness about the disease, can also affect patient outcomes and management strategies[12].

Conclusion

Low-tension glaucoma is a complex condition that requires careful monitoring and management due to its subtle clinical presentation and potential for significant visual impairment. Regular eye examinations and awareness of risk factors are essential for early detection and intervention. Understanding the signs, symptoms, and patient characteristics associated with LTG can help healthcare providers offer better care and support to affected individuals.

For further management, it is crucial to consider both medical and surgical options tailored to the individual patient's needs, as well as ongoing monitoring to assess disease progression and treatment efficacy.

Description

Low-tension glaucoma, classified under ICD-10 code H40.123, is a specific type of glaucoma characterized by optic nerve damage and visual field loss despite having intraocular pressure (IOP) within the normal range. This condition is particularly significant because it can often go undetected until substantial damage has occurred, as patients may not exhibit the typical symptoms associated with higher IOP levels.

Clinical Description

Definition and Characteristics

Low-tension glaucoma, also known as normal-tension glaucoma, occurs when the optic nerve sustains damage even though the IOP remains below the threshold typically associated with glaucoma (generally considered to be 21 mmHg or lower). The exact cause of this condition is not fully understood, but it is believed to involve factors such as:

  • Vascular insufficiency: Reduced blood flow to the optic nerve may contribute to nerve damage.
  • Optic nerve susceptibility: Some individuals may have a genetically predisposed vulnerability to optic nerve damage.
  • Other systemic conditions: Conditions such as systemic hypotension or sleep apnea may also play a role in the development of low-tension glaucoma.

Symptoms

Patients with low-tension glaucoma may not experience noticeable symptoms in the early stages. As the disease progresses, they may begin to notice:

  • Peripheral vision loss: This is often the first sign, where patients may not realize they are missing parts of their visual field.
  • Difficulty adapting to darkness: Patients may find it challenging to see in low-light conditions.
  • Visual disturbances: Some may experience blurred vision or other visual anomalies.

Diagnosis

Diagnosis of low-tension glaucoma typically involves a comprehensive eye examination, which may include:

  • Tonometry: To measure IOP.
  • Visual field testing: To assess peripheral vision loss.
  • Optic nerve examination: Using techniques such as optical coherence tomography (OCT) to evaluate the health of the optic nerve and detect any damage.

Management and Treatment

Management of low-tension glaucoma focuses on lowering the risk of further optic nerve damage. Treatment options may include:

  • Medications: Prostaglandin analogs, beta-blockers, or carbonic anhydrase inhibitors may be prescribed to lower IOP, even if it is within the normal range.
  • Laser therapy: Procedures such as selective laser trabeculoplasty (SLT) may be considered to improve aqueous outflow.
  • Surgical options: In some cases, surgical interventions like trabeculectomy or the placement of drainage devices may be necessary.

Conclusion

Low-tension glaucoma (ICD-10 code H40.123) is a critical condition that requires careful monitoring and management due to its insidious nature and potential for significant visual impairment. Early detection through regular eye examinations is essential, especially for individuals at higher risk, such as those with a family history of glaucoma or other risk factors. Ongoing research continues to explore the underlying mechanisms and optimal treatment strategies for this challenging form of glaucoma, emphasizing the importance of individualized patient care.

Approximate Synonyms

Low-tension glaucoma, classified under the ICD-10 code H40.123, is a specific type of glaucoma characterized by optic nerve damage and visual field loss despite normal intraocular pressure levels. Understanding alternative names and related terms for this condition can enhance clarity in medical documentation and communication. Below are some alternative names and related terms associated with H40.123.

Alternative Names for Low-Tension Glaucoma

  1. Normal-Tension Glaucoma (NTG): This term is commonly used interchangeably with low-tension glaucoma, emphasizing that the intraocular pressure remains within the normal range while optic nerve damage occurs[1].

  2. Aphakic Glaucoma: Although not exclusively synonymous, this term can sometimes be associated with low-tension glaucoma, particularly in patients who have undergone cataract surgery and have an artificial lens implanted, which may influence intraocular pressure dynamics[2].

  3. Optic Nerve Head Damage: This phrase describes the underlying pathology of low-tension glaucoma, focusing on the damage to the optic nerve head that characterizes the condition[3].

  1. Glaucoma: A broader term that encompasses various types of glaucoma, including low-tension glaucoma, characterized by increased intraocular pressure and optic nerve damage[4].

  2. Bilateral Glaucoma: This term indicates that the condition affects both eyes, which is a defining characteristic of the H40.123 code[5].

  3. Mild Stage Low-Tension Glaucoma: This term refers to a specific classification within low-tension glaucoma, denoted by the code H40.1231, indicating a less severe form of the condition[6].

  4. Chronic Open-Angle Glaucoma: While not directly synonymous, this term can sometimes overlap with low-tension glaucoma, particularly in cases where the angle of the anterior chamber remains open, but the pressure is low[7].

  5. Visual Field Loss: This term is often used in clinical settings to describe one of the primary symptoms of low-tension glaucoma, highlighting the impact on vision[8].

Conclusion

Understanding the alternative names and related terms for low-tension glaucoma (ICD-10 code H40.123) is essential for accurate diagnosis, treatment, and communication among healthcare professionals. Terms like normal-tension glaucoma and bilateral glaucoma help clarify the condition's nature, while related terms provide context regarding its symptoms and classifications. For healthcare providers, using these terms appropriately can enhance patient care and ensure precise medical records.

Diagnostic Criteria

Low-tension glaucoma, classified under ICD-10 code H40.123, is a specific type of glaucoma characterized by optic nerve damage and visual field loss despite normal intraocular pressure (IOP) levels. The diagnosis of low-tension glaucoma involves several criteria and clinical assessments to differentiate it from other types of glaucoma. Below are the key criteria used for diagnosis:

Diagnostic Criteria for Low-Tension Glaucoma (ICD-10 H40.123)

1. Intraocular Pressure Measurement

  • Normal IOP Levels: The primary criterion for low-tension glaucoma is that the intraocular pressure must be consistently within the normal range, typically defined as less than 21 mmHg. This distinguishes it from other forms of glaucoma where elevated IOP is a hallmark feature[1].

2. Optic Nerve Assessment

  • Optic Nerve Damage: Examination of the optic nerve head is crucial. Signs of damage may include:
    • Cupping of the optic disc (increased cup-to-disc ratio).
    • Pallor of the optic disc.
    • Notching or other structural changes indicative of glaucomatous damage[2].

3. Visual Field Testing

  • Visual Field Defects: Patients must exhibit characteristic visual field loss patterns, which may include:
    • Peripheral vision loss.
    • Nasal steps or arcuate scotomas.
  • These defects should be reproducible and consistent with glaucomatous damage[3].

4. Exclusion of Other Causes

  • Rule Out Secondary Causes: It is essential to exclude other potential causes of optic nerve damage and visual field loss, such as:
    • Other types of glaucoma (e.g., primary open-angle glaucoma).
    • Neurological conditions.
    • Retinal diseases.
  • A comprehensive medical history and additional diagnostic tests may be necessary to confirm that the observed changes are not due to other conditions[4].

5. Patient Symptoms and History

  • Symptom Review: While many patients with low-tension glaucoma may be asymptomatic in the early stages, any reported symptoms such as blurred vision or difficulty with night vision should be documented.
  • Family History: A family history of glaucoma can also be a relevant factor in the diagnosis, as genetic predisposition plays a role in the condition[5].

6. Additional Diagnostic Tests

  • Gonioscopy: This test may be performed to assess the angle of the anterior chamber and rule out angle-closure glaucoma.
  • Optical Coherence Tomography (OCT): This imaging technique can provide detailed images of the optic nerve and retinal nerve fiber layer, helping to assess the extent of damage[6].

Conclusion

Diagnosing low-tension glaucoma (ICD-10 code H40.123) requires a multifaceted approach that includes measuring intraocular pressure, assessing optic nerve health, conducting visual field tests, and ruling out other potential causes of optic nerve damage. Regular monitoring and comprehensive eye examinations are essential for managing this condition effectively, as early detection can help prevent significant vision loss. If you have further questions or need more detailed information on specific aspects of the diagnosis, feel free to ask!

Treatment Guidelines

Low-tension glaucoma, classified under ICD-10 code H40.123, is a form of glaucoma characterized by optic nerve damage and visual field loss despite normal intraocular pressure (IOP) levels. This condition can be particularly challenging to diagnose and manage due to its atypical presentation. Here, we will explore standard treatment approaches for managing bilateral low-tension glaucoma.

Understanding Low-Tension Glaucoma

Low-tension glaucoma (LTG) is often associated with risk factors such as vascular dysregulation, systemic hypotension, and other ocular conditions. Patients may not exhibit the elevated IOP typically seen in other forms of glaucoma, making regular screening and monitoring essential for early detection and intervention[1].

Standard Treatment Approaches

1. Medications

The first line of treatment for low-tension glaucoma typically involves the use of topical medications aimed at lowering IOP, even if baseline pressures are within normal limits. Common classes of medications include:

  • Prostaglandin analogs: These are often the first choice due to their efficacy in reducing IOP. They work by increasing uveoscleral outflow of aqueous humor. Examples include latanoprost and bimatoprost[2].

  • Beta-blockers: Medications such as timolol can reduce aqueous humor production, thereby lowering IOP. They are particularly useful for patients who may not tolerate prostaglandin analogs[3].

  • Alpha agonists: Drugs like brimonidine can also decrease aqueous humor production and increase outflow, providing an additional option for managing IOP[4].

  • Carbonic anhydrase inhibitors: Topical agents like dorzolamide can be used to further reduce aqueous humor production, especially in patients who require additional IOP control[5].

2. Laser Therapy

In cases where medications are insufficient or not tolerated, laser treatments may be considered:

  • Laser trabeculoplasty: This procedure can enhance aqueous outflow through the trabecular meshwork, potentially lowering IOP. It is often used in conjunction with medical therapy[6].

  • Selective laser trabeculoplasty (SLT): A more recent advancement, SLT is less invasive and can be repeated if necessary, making it a suitable option for patients with low-tension glaucoma[7].

3. Surgical Interventions

For patients who do not respond adequately to medications or laser therapy, surgical options may be explored:

  • Aqueous shunts and stents: These devices can help facilitate aqueous humor drainage, thereby reducing IOP. They are particularly beneficial in cases of advanced glaucoma or when other treatments have failed[8].

  • Trabeculectomy: This surgical procedure creates a new drainage pathway for aqueous humor, effectively lowering IOP. It is typically reserved for more severe cases or when other treatments have not been successful[9].

4. Monitoring and Follow-Up

Regular follow-up appointments are crucial for patients with low-tension glaucoma. Monitoring IOP, visual field changes, and optic nerve health helps assess treatment efficacy and make necessary adjustments. Patients should also be educated about the importance of adherence to prescribed therapies and lifestyle modifications that may support overall ocular health[10].

Conclusion

Managing bilateral low-tension glaucoma requires a comprehensive approach that includes pharmacological treatment, potential laser therapy, and surgical options when necessary. Given the unique challenges posed by this condition, individualized treatment plans tailored to each patient's specific needs and responses are essential. Ongoing monitoring and patient education play critical roles in ensuring optimal outcomes and preserving vision in individuals affected by this form of glaucoma.

For further information or specific case management strategies, consulting with a glaucoma specialist is recommended.

Related Information

Clinical Information

  • Damage to optic nerve with normal IOP
  • Visual field loss despite normal pressure
  • Reduced blood flow to optic nerve suspected
  • Increased cup-to-disc ratio observed
  • Pallor of optic nerve head noted
  • Nocturnal vision issues reported
  • Eye discomfort or headaches experienced
  • Age over 40 at diagnosis common
  • Higher prevalence in women and Asian descent
  • Family history increases risk significantly
  • Systemic conditions contribute to risk
  • Vascular factors increase optic nerve damage

Description

  • Optic nerve damage without high eye pressure
  • Visual field loss in normal tension patients
  • Vascular insufficiency contributes to damage
  • Genetic susceptibility to optic nerve damage
  • Peripheral vision loss is first symptom
  • Difficulty adapting to darkness occurs later
  • Medications used to lower intraocular pressure

Approximate Synonyms

  • Normal-Tension Glaucoma (NTG)
  • Aphakic Glaucoma
  • Optic Nerve Head Damage
  • Glaucoma
  • Bilateral Glaucoma
  • Mild Stage Low-Tension Glaucoma
  • Chronic Open-Angle Glaucoma

Diagnostic Criteria

  • Normal IOP levels (less than 21 mmHg)
  • Optic nerve damage with cupping
  • Visual field defects (peripheral vision loss)
  • Exclude other causes of optic nerve damage
  • Symptoms (blurred vision, night vision difficulty)
  • Family history of glaucoma
  • Gonioscopy for angle assessment
  • OCT imaging for retinal nerve fiber layer

Treatment Guidelines

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.